secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001607062-22-000724
Event type: debt
Sentiment:  negative
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 55.8M Series A Preferred shares to settle $376,711 in convertible debt
--------------------------------------------------------------------------------

- Issued 55,809,233 Series A Preferred shares to satisfy $250,000 principal and $126,711 accrued interest on convertible promissory notes.
- Shares issued directly by management under Section 4(a)(2) exemption; no underwriters or commissions paid.
- As of Nov 21, 2022, $510,000 of convertible notes outstanding, including $360,000 convertible at floating rate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000724/0001607062-22-000724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000724/rgbp112122form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer